Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery. - Wikidata - awgldk - TriplyDB

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

http://www.wikidata.org/entity/Q38002853

about

Mesoporous silica nanoparticles in target drug delivery system: A review Delivery of cancer therapeutics using nanotechnology Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.Recent advances in siRNA delivery.An NIR-triggered and thermally responsive drug delivery platform through DNA/copper sulfide gates.Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery Contemporary mesoporous materials for drug delivery applications: a review

P2860

Q26799990-370D93F8-03C7-4043-A49C-A395CA75150E Q30446963-643392D6-D9C8-4D69-BA69-15DF23663B36 Q35767648-50696E38-B316-4E35-BB9D-DF966310B206 Q36103833-753E8CCA-92EF-4E67-974A-835F4C34C556 Q37157022-042F54AB-280B-4CC9-8E86-C722DFA46DDF Q38563960-836EAB67-55BB-4A33-AEE3-7DB655004D41 Q38648525-E0F8E629-4E68-4A2E-AF9F-BDE755E05DDB Q53438846-13EA0ABA-5D72-4158-9A16-C81E6FC89297 Q55228197-83F4A850-3761-44CC-9864-F21BFAF2589D Q57342490-B5873EF1-3793-44DD-9D99-19D1445D0F9D Q57347611-133AFE88-511D-4351-8F9E-986702DD276D

P2860

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

http://www.wikidata.org/entity/Q38002853

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

@en

type

label

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

@en

prefLabel

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

@en

P1433

Q38002853-4180612F-D3CE-44F8-A74F-163A0DEAE504

P1476

Q38002853-BB86CB1A-32C1-49CF-9765-4DC02F87158F

P2093

Q38002853-B1CDDFA3-5ACF-4AF3-97CA-A49A03D0E03C

Q38002853-F073568D-56FB-4F3A-9BBD-1C870F4CF2F0

P2860

Q38002853-05CF86B4-7E64-4CFD-BF3B-24557B0A3FF9

Q38002853-13C4C681-4811-473D-B4FF-86773D238A1B

Q38002853-14412567-807C-4CDA-B406-069DA86837B5

Q38002853-1473CA3C-7182-4395-80D9-49DC7035D8FF

Q38002853-17475EB6-A643-45E2-A81C-622360C466D3

Q38002853-2243AD67-0D7F-4FCA-B1EA-08E7A0BBE680

Q38002853-236B4129-8B8B-44B2-9FD3-CCCCFA0B96A6

Q38002853-25793A52-FEA5-43E5-BC8B-3CFD2C88B720

Q38002853-25A75357-B4EF-4043-9A5E-B9DD41385273

Q38002853-297DC9D0-1612-4080-9342-DCD140C9990F

P304

Q38002853-D2CD1172-8CA6-45A2-A075-534C9171F29C

P31

Q38002853-6C0C5E23-9BCE-42AD-9E01-5D619C33ADD1

P356

Q38002853-D0E70FB2-2C5C-4249-BDA9-60AB7BE080E0

P433

Q38002853-FE6A5228-3443-4FA5-B227-5DCADDF397DA

P478

Q38002853-98B2090F-3F5A-4AA9-9522-A60583FB40AB

P577

Q38002853-C18C766A-CF2D-481B-AA8B-A647B0BF010A

P5875

Q38002853-8F52D2EB-98B7-4704-B5A2-0F3F7550EF74

P698

Q38002853-19315B2C-1F0C-47D6-A5C8-FFE0C907AAA3

P921

Q38002853-0B44B5A6-5690-4F3B-BC41-FB9F8F3AB3D9

Q38002853-2801B6CA-531D-4C0B-83C5-9918215C540E

P932

Q38002853-3FBDDA26-FB80-46CA-8EA8-F9D2B03DCE06

P356

P1433

Therapeutic delivery

P1476

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

@en

P2093

Fuyuhiko Tamanoi

http://www.w3.org/2001/XMLSchema#string

Rolando E Yanes

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular engineering: An approach to the development of general capabilities for molecular manipulation

Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.

A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.

Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells

Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles.

P304

389-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE.12.9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224050296

http://www.w3.org/2001/XMLSchema#string

P698

22506096

http://www.w3.org/2001/XMLSchema#string

P921

P932

3324307

http://www.w3.org/2001/XMLSchema#string